there is clinical or epidemiological evidence of influenza A virus infection. Although virus isolation is a standard method for influenza virus diagnosis, reverse transcription-polymerase chain reaction (RT-PCR) offers an alternative method which can be used for rapid detection of the influenza virus genome. With multiplex polymerase chain reaction, more than one target sequence can be amplified by including more than one pair of primers in the same reaction (Elnifro et al. 2000) . Therefore, multiplex PCR represents a method which is less laborious and time consuming as several influenza virus genes can be amplified simultaneously.
In this study, two multiplex PCR assays were developed for, firstly, typing influenza A and B virus with a set of three primer pairs specific for the M gene of influenza A and influenza B virus, and the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene (a house-keeping gene of host cells) serving as an internal control. Secondly, for subtyping influenza A viruses a set of specific primers was designed to amplify the HA subtypes H1, H3, and H5 of currently circulating influenza A viruses.
MATERIALS AND METHODS

Sources of clinical specimens
Of 46 specimens, 35 specimens were influenza A virus positive and 11 specimens were influenza B virus positive. The influenza A virus positive specimens comprised human H1N1 (n = 8), human H3N2 (n = 10), human H5N1 (n = 1), avian H5N1 (n = 15), and dog H5N1 (n = 1). The H5N1 subtype can be further divided into 2 clades, clade 1 (n = 15) and clade 2 subclade 3 (n = 2). Each sample's details are shown in Table 1 .
Primer design
For the influenza virus typing assay, primers were selected from conserved nucleotide sequences specific for the M genes of influenza A and B viruses, as well as the house keeping gene, GAPDH, as an internal control. In order to design the influenza A virus M gene specific primer, the M gene nucleotide sequences from 15 subtypes of HA with a variable NA gene in each host were selected from the GenBank database. These sequences were aligned using the ClustalX (Thompson et al. 1997) program. The most conserved region was chosen to Influenza virus infection has remained a major public health concern as it causes yearly epidemics mostly during the winter months. Influenza virus infection is associated with a diverse clinical spectrum, ranging from asymptomatic infection over respiratory symptoms such as high fever (> 38°C) and either cough or sore throat (influenza-like illness) to severe complications due to secondary bacterial infections (Nicholson et al. 2003) . Moreover, influenza virus infection can occasionally incur the severe and fatal complication of acute pulmonary microthromboembolism (Ohrui et al. 2000) .
Influenza viruses are members of the Orthomyxoviridae family and can be classified into types A, B and C, according to antigen variations in their nucleoprotein (NP) and matrix (M) protein. Most influenza pandemics are associated with type A. Influenza A viruses can be further classified into subtypes based on the antigen differences between their hemagglutinin (HA) and neuraminidase (NA) surface glycoprotein. Up to now, 16 HA and 9 NA subtypes of influenza A viruses have been identified (Fouchier et al. 2005) .
At present, seasonally circulating influenza viruses in humans are influenza A virus subtypes H1N1 and H3N2 as well as influenza B virus. Since late 2003, outbreaks of highly pathogenic avian influenza A virus (HPAI) subtype H5N1 have been reported to infect poultry in Asia and subsequently in Europe and Africa. Moreover, human infections with this subtype have increasingly been diagnosed. WHO has documented 348 confirmed human cases infected with this virus with a mortality rate exceeding 60% (WHO 2007) . However, most patients infected with the highly pathogenic H5N1 subtype initially display the typical influenza symptoms of high fever and an influenza-like illness (Beigel et al. 2005) . Due to continuous H5N1 outbreaks in Asia and great genetic variability of this virus, a rapid and sensitive diagnostic assay is crucial for suitable clinical management and prevention of further virus transmission.
Hence, it is essential to test specimens from influenza-like illness patients, in cases where design the forward and reverse primers. For the assay aimed at determining subtypes H1, H3 and H5 of influenza A virus, primers were chosen specifically from the conserved regions of each HA gene's subtype. The primers were designed and analyzed by using the PCR primer software, FastPCR Version 4.0.27 by Ruslan Kalendar, (Institute of Biotechnology, University of Helsinki, Finland) to ascertain that they could be combined in a multiplex PCR format. All primer sequences are shown in Table 2 .
RNA Extraction and Reverse transcription
As for nasopharyngeal suction samples, RNA was extracted from 150 μ l of each sample using TRI REAGENT ® LS (Molecular Research Center, Inc., Cincinnati, OH, USA) and dissolved in 12 μ l of DEPC treated water. As for embryonated chicken egg allantoic fluid, RNA was extracted from 140 μ l allantoic fluid of each sample using the QIAmp viral RNA mini kit (Qiagen, GmbH, Hilden, Germany) according to the manufacturer's specifications. The reverse transcription was performed using Moloney murine leukemia virus (MMLV) reverse transcriptase (Promega, Madison, WI, USA). The reaction mixture comprised 5 μ l of 5x MMLV reaction Buffer, 5 μ l of 10 mM dNTP, 40 units of RNasin ® ribonuclease inhibitor, 200 units of M-MLV reverse transcriptase, 0.5 μ g of random hexamer, 12 μ l of RNA preheated to 70°C for 5 min then cooled on ice and nuclease-free water to a final volume of 25 μ l. Subsequently, this reaction mixture was incubated at 37°C for 60 min. The resulting cDNAs were stored at −20°C until employed in the multiplex PCR reaction mixture.
Multiplex PCR and Thermal cycling conditions
Two separate reactions of multiplex PCR for typing and subtyping influenza virus were prepared. The reaction mixture of both reactions contained 10 μ l of 2.5X Eppendorf MasterMix (Eppendorf, Hamburg, Germany), 3 mM Mg 2+ , 200 μ M dNTPs, each set of primers for typing and subtyping at the final concentration of each primer equal to 0.4 μ M, 1 μ l of cDNA template and sterile water to a total volume of 25 μ l. Both typing and subtyping multiplex PCR assays were performed in a Mastercycler personal (Eppendorf) under the following conditions. Pre-denaturation at 94°C for 3 min, followed by 45 cycles at 94°C for 30 sec (denaturation), 58°C for 30 sec (primer annealing), 72°C for 1 min (extension) and concluded by a final extension step at 72°C for 7 min.
Agarose gel electrophoresis
A total of 10 μ l PCR products were mixed with loading buffer and run on a 1.5% agarose gel at 100 Volts for 60 min. After electrophoresis, the respective DNA bands were stained with ethidium bromide (FMC Bioproducts, Rockland, ME, USA) and then visualized on a UV transilluminator. The expected sizes of each PCR amplified product are summarized in Table 2 .
Nucleotide Sequencing
Type and subtype of samples whose sequence was lacking in the database were confirmed by sequencing. After PCR amplicons were analyzed by 1.5% agarose gel electrophoresis and purified using the Perfectprep Gel Cleanup Kit (Eppendorf), direct DNA sequencing was performed using the Big Dye Terminator V.3.0 Cycle Sequencing Reaction kit (ABI, Foster City, CA, USA). The reactions were carried out in an ABI-Prism 310 Genetic Analyzer (Perkin Elmer, Norwalk, CT, USA). The initial sequences were edited and analyzed by Chromas Lite version 2.01 (Technelysium Pty Ltd., Australia) and the Bioedit Sequence Alignment Editor V.7.0.5.3 (Hall 1999) . Subtypes of influenza A viruses were determined by BLAST analysis.
Positive controls
To optimize the influenza virus typing (A/B) and subtyping (H1/H3 and H5) assays, a total of six plasmid 
Specificity test
The specificity of the multiplex PCR assays was evaluated by cross-reaction tests with cDNA obtained from other subtypes of influenza A viruses (H2-H4 and H6-H15) as shown in Table 2 . These subtypes of influenza A virus specimens were kindly provided by the Department of Livestock Development, Bangkok, Thailand. The assays were also evaluated against other respiratory viruses including human bocavirus (HBoV) (n = 9), adenovirus (n = 16), parainfluenza (PIVs) (n = 12), respiratory syncytial virus (RSV) subgroups A & B (n = 24), human metapneumovirus (hMPV) (n = 22) first 
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described by Chieochansin et al. (2007) as well as respiratory bacteria including Haemophilus influenzae (n = 1), Streptococcus pyogenes (n = 1), Streptococcus pneumoniae (n = 1) and Staphylococcus aureus (n = 1).
RESULT
In this study, a multiplex RT-PCR assay for typing and subtyping influenza virus was developed by using two specific primer sets. To establish influenza virus type, the conserved regions in M genes of influenza A and B virus were amplified. The clearly distinguishable amplicons of influenza A and B virus are shown in Fig. 1A . The PCR product size after amplification of influenza A and B virus were 214 bp and 296 bp, respectively. In this typing assay, a primer specific for the GAPDH gene was added to ascertain that in the specimen collection and RNA extraction step we did obtain cells and RNA. Therefore, every positive result of influenza A or B virus typing must also display the GAPDH band at 107 bp which simultaneously rules out false positive results.
In order to subtype influenza A virus, the conserved and specific regions of the HA gene of H1, H3 and H5 subtype were amplified. This assay provided different product sizes representing each influenza A virus subtype. The product sizes of H1, H3 and H5 were 362, 112 and 188 bp, respectively. The results of the subtyping assay are shown in Fig. 1B . For all specimens tested, the typing and subtyping results obtained by multiplex PCR were in complete agreement with type or subtype determinations by direct nucleotide sequencing. The specimens were identified as either influenza A (H1N1, H3N2 and H5N1) or B as shown in Table 1 .
The assay detection limit was established by using 10-fold serial dilutions (10 9 or 10 8 -10 copies/μ l) of standard plasmid DNA of each gene. Amplified products were visible at plasmid DNA concentrations as low as 10 3 copies/μ l of the M gene of influenza A and B, GAPDH, H3 and H5 plasmid. To detect the H1 plasmid concentrations of 10 4 copies/μ l were required (data not shown).
Among a combination of all plasmids employed in the typing assay (M gene of Flu A and B and GAPDH; 1:1:1 ratio) the sensitivity of the assay was approximately 10 3 -10 4 copies/μ l ( Fig. 2A) , while the sensitivity of the subtyping (H1, H3 and H5; 1:1:1 ratio) assay was approximately 10 4 copies/μ l (Fig. 2B ). For the specificity test, cDNA obtained from other subtypes of influenza A viruses including H2N2, H3N8, H4N6, H6N2, H7N7, H8N4, H9N2, H10N7, H11N6, H12N5, H13N6, H14N5 and H15N8 were used as templates. The results showed that all subtypes of influenza A viruses (H1-H15) could be amplified with the primers specific for the M gene of influenza A virus, indicating the broad detection range of the primers in the typing assay. The subtyping assay produced the specific bands corresponding to H1, H3 and H5 subtypes only, demonstrating the high specificity of the primers as shown in Fig. 3 . These results proved the suitability of primer sets and multiplex PCR conditions for successful influenza virus typing and subtyping.
DISCUSSION
The rapid and accurate diagnosis of respiratory viruses is essential to improve patient management and provide information as to which preventive measures may be taken. This is particularly important with H5N1 avian influenza infection whose initial clinical symptoms are indistinguishable from seasonal influenza or other respiratory virus infections. In addition, the subtyping assay can detect co-infections of H1, H3 and/or H5 viruses which may result in genetic reassortment between avian and human influenza viruses. Identification of the pathogen will limit unnecessary administration of antibiotics and increase effectiveness of treatment.
Methods appropriate for influenza diagnosis ought to be highly accurate, sensitive, specific and rapid. Virus culture, the most accurate method, is still considered the gold standard. Yet, its limitation lies in the time required to achieve results, which especially with H5N1 infected patients might negatively impact the outcome.
Previous studies suggest that multiplex PCR could resolve the limitations associated with traditional diagnostic techniques by combining increased sensitivity, specificity, and rapid achievement of results and thus, effectively detect multiple respiratory infections (Bellau-Pujol et al. 2005) . Live virus is not necessary for the multiplex PCR assay to detect the viral genome and thus, it is more flexible for specimen collection and transportation than virus isolation. Several studies have reported simultaneous influenza type and subtype detection by multiplex RT-PCR as for example, a multiplex RT-PCR for H1N1, H3N2, H5N1 and type B detection (Poddar 2002) , for detection of H5 and H7 avian influenza viruses (Thontiravong et al. 2007 ) and a single step reaction for H5N1 detection (Payungporn et al. 2004 ). Hence, multiplex PCR can be widely used for influenza virus detection because the reagents and equipment required for the assays are accessible in many countries. According to the high degree of mutations within the HA and NA genes, it may be necessary to update the primer sequences for detection of particular subtypes. Since our assays used primer sequences that were based on circulating strains of influenza viruses, this represented an improvement over other assays. In the present study, two multiplex PCR assays were developed to simultaneously detect influenza viruses A and B, as well as discriminate between the subtypes capable of infecting humans, H1, H3 and H5. Especially with respect to the H5 subtype, our primer was specifically designed in relation to the recent outbreaks of H5N1 which can be divided into 2 clades. The result showed that the H5 subtyping primer can amplify both clades. Both reactions could be accomplished under simple conditions without the necessity for nested PCR. Moreover, the PCR products could be clearly separated by agarose gel electrophoresis. Applying these assays, the seasonally circulating human influenza viruses (H1N1, H3N2 and type B) including the highly pathogenic subtype H5N1 can reliably be diagnosed.
In conclusion, the multiplex RT-PCR assays described here provide a simple, rapid and cost effective method for influenza virus type and subtype detection from avian, mammalian and also human clinical specimens and hence, ought to be implemented for large-scale detection aimed at controlling influenza virus outbreaks.
